Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD
- PMID: 16478847
- PMCID: PMC7094441
- DOI: 10.1378/chest.129.2.317
Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD
Abstract
Study objectives: The inflammatory responses and associated clinical severity of COPD exacerbations are greatly variable, and the determinants of these factors are poorly understood. We examined the hypothesis that bacteria and viruses may modulate this heterogeneity and that interactions between bacterial and viral infection may affect changes in airway bacterial load and the clinical features and inflammatory responses of exacerbations in patients with COPD.
Design: Prospective cohort study.
Setting: Outpatient Department, London Chest Hospital, London, UK.
Patients: Thirty-nine patients with COPD.
Measurements: We prospectively studied 56 COPD exacerbations, obtaining clinical data and paired sputum and serum samples at baseline and exacerbation. Qualitative and quantitative microbiology, polymerase chain reaction detection for rhinovirus, and estimation of cytokine levels by enzyme-linked immunosorbent assay were performed.
Results: A total of 69.6% of exacerbations were associated with a bacterial pathogen, most commonly Haemophilus influenzae. Rhinovirus was identified in 19.6% of exacerbations. The rise in bacterial load at exacerbation correlated with the rise in sputum interleukin (IL)-8 (r = 0.37, p = 0.022) and fall in FEV1 (r = 0.35, p = 0.048). Exacerbations with both rhinovirus and H. influenzae had higher bacterial loads (10(8.56) cfu/mL vs 10(8.05)cfu/mL, p = 0.018) and serum IL-6 (13.75 pg/mL vs 6.29 pg/mL, p = 0.028) than exacerbations without both pathogens. In exacerbations with both cold symptoms (a marker of putative viral infection) and a bacterial pathogen, the FEV1 fall was greater (20.3% vs 3.6%, p = 0.026) and symptom count was higher (p = 0.019) than those with a bacterial pathogen alone.
Conclusions: The clinical severity and inflammatory responses in COPD exacerbations are modulated by the nature of the infecting organism: bacterial and viral pathogens interact to cause additional rises in inflammatory markers and greater exacerbation severity.
Figures



Comment in
-
Coinfection in exacerbations of COPD: a new frontier.Chest. 2006 Feb;129(2):223-224. doi: 10.1378/chest.129.2.223. Chest. 2006. PMID: 16478834 No abstract available.
References
-
- Hill A, Campbell EJ, Hill SL. Association between bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000;109:288–295. - PubMed
-
- Wedzicha JA, Seemungal TAR, MacCallum PK. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000;84:210–215. - PubMed
-
- Seemungal TAR, Donaldson GC, Bhowmik A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–1613. - PubMed
-
- Seemungal TAR, Harper-Owen R, Bhowmik A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1618–1623. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical